Breaking News
Get 40% Off 0
🔎 See NVDA's full ProTips for an instant risks or rewards Claim 40% OFF
Close

Bristol-Myers Squibb Company (BMY)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Bristol-Myers Squibb's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
49.86 0.00    0.00%
- Real-time Cboe. Currency in USD ( Disclaimer )
Type:  Equity
Market:  United States
  • Volume: 3,466,672
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 49.53 - 50.10
Bristol-Myers Squibb 49.86 0.00 0.00%

NYSE:BMY Financials

 
A brief overview of the NYSE:BMY financials. This summary provides an overview of the most significant critical numbers from each of its financial reports, including the income statement, balance sheet, and cash flow statement. Additionally, it features several financial ratios that provide insight into the company's financial health. Users can select to view data from four periods of either annual or quarterly information, allowing them to track financial performance of Bristol over time.

Bristol-Myers Squibb Company reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported sales was USD 321 million compared to USD 405 million a year ago. Revenue was USD 10,966 million compared to USD 11,218 million a year ago. Net income was USD 1,928 million compared to USD 1,606 million a year ago. Basic earnings per share from continuing operations was USD 0.94 compared to USD 0.75 a year ago. Diluted earnings per share from continuing operations was USD 0.93 compared to USD 0.75 a year ago.For the nine months, sales was USD 919 million compared to USD 1,147 million a year ago. Revenue was USD 33,529 million compared to USD 34,753 million a year ago. Net income was USD 6,263 million compared to USD 4,305 million a year ago. Basic earnings per share from continuing operations was USD 3.01 compared to USD 2.01 a year ago. Diluted earnings per share from continuing operations was USD 2.99 compared to USD 2 a year ago.

AnnualQuarterly  
InvestingPro Advanced Financial Summary
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

BMY Income Statement

Gross margin TTM 76.63%
Operating margin TTM 19.22%
Net Profit margin TTM 17.83%
Return on Investment TTM 10.05%
 Total Revenue  Net Income
Period Ending: Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023
Total Revenue 11477 10966 11226 11337
Gross Profit 8770 8476 8417 8825
Operating Income 1952 2104 1994 2506
Net Income 1762 1928 2073 2262

BMY Balance Sheet

Quick Ratio MRQ 1.06
Current Ratio MRQ 1.43
LT Debt to Equity MRQ 124.74%
Total Debt to Equity MRQ 141.08%
 Total Assets  Total Liabilities
Period Ending: Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023
Total Assets 95159 91263 93489 94281
Total Liabilities 65674 62201 61459 62395
Total Equity 29485 29062 32030 31886

BMY Cash Flow Statement

Cash Flow/Share TTM 6.81
Revenue/Share TTM 22.12
Operating Cash Flow  19.10%
 Cash  Net Change in Cash
Period Ending: Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023
Period Length: 0 Months 0 Months 0 Months 0 Months
Cash From Operating Activities 4252 4751 1887 2970
Cash From Investing Activities -1346 -410 -329 -210
Cash From Financing Activities 967 -5160 -2173 -3050
Net Change in Cash 3951 -857 -623 -277
* In Millions of USD (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

BMY Comments

Write your thoughts about Bristol-Myers Squibb Company
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Feb 06, 2024 5:39PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Without having a trusted person to help you make it huge in investing dose sound good to me , my wife just made me happy since morning I haven't been able to keep down the happiness in heart I have nothing to say then God bless you for the payout form the last investment ...his wasp. (+)31612574318). 1001010010101010100101010100101010101010101001010101010101010100101010101010100101010101010101010110101010101001101010101001010101100101101001101001010110100110110010101101010011010100101100101011010101001100101010110
david lee
david lee Feb 06, 2024 10:43AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
this is big sale
david lee
david lee Feb 06, 2024 10:35AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
buying...
Feb 06, 2024 10:09AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
sale to 44
Feb 05, 2024 3:22PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Bristol Myers Squibb Named One of America’s Most JUST Companies by JUST Capital and CNBC
Feb 05, 2024 12:52PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
This is a stock that must only go up according to all the data and reports!
david lee
david lee Feb 05, 2024 12:30PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
big sale...
Feb 05, 2024 11:39AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
40 dolar
Feb 05, 2024 11:37AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
big sale
Feb 05, 2024 11:26AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
go to 40d
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email